Cancer clippingsEvolving drug resistance, etc
- Introduction to the series
- Introduction to cancer cell and molecular biology and genetics: cancer as a genetic disease; cancer as a disease of cell-cycle regulation; oncogenes, TSGs, apoptosis and DNA repair mechanisms
- Introduction to evolution: populations in an environment; the conditions for evolution, proliferation, imperfect replication, competition; the gene-centered view; evolution in the individual as we age; evolution is not teleological
- Introduction to tumour evolution and the adaptations we see:
- the microenvironment and the selection pressures it produces (hypoxia central amongst them)
- why cancer is not "microevolution" but a minuture version of "macroevolution" in terms of population and ecology
- Knudsen multi-hit
- chromosomal instability
- cancer stem cells
- perhaps an item on chromatin/epigenetics/methylation
- A post on each of the common adaptations (include cellular and molecular details, drugs that target them, etc):
- Loss of DNA checkpoints (pre- and post- replication) and repair mechanisms (p53, BRCA, predispositions, link to chromosomal instability and things like Bloom syndrome?)
- Dysregulation of cell-cycle (oncogenes and TSGs w. her2+rb examples?, CDCs, CDKs, cyclins)
- Loss of apoptosis (include intro to telomeres here?)
- Stealing nutrients: dysregulated glycolysis, anaerobic respiration
- Angiogenesis and vasculogenesis (vegf, link to the DS stuff, anti-angiogenic drugs)
- Dodging the immune system (include how radiotherapy counters this)
- Invasion and metastasis (MMPs)
- Drug resistance (link back to pharmacogenomics)
- Convergent evolution: discuss how it differs in cancer compared to in the field (more homogenous environment, more homogenous starting point).
- Side series: important and quirky people in the story:
- Cell-cycle: Hunt, Nurse, and Hartwell
- Apoptosis: Folkman
Possible sources:
0.10022687911987 secs
|